Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients
Clinical trial NCT03627026 · COMPLETED
Trial details
- NCT number
- NCT03627026
- Sponsor
- Institut Claudius Regaud
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-11
- Primary completion
- 2023-09-08
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.